发布求助
文献互助 智能选刊 最新文献

Pharmaceutical science & technology today最新文献

筛选
英文 中文
Anti-vascular targeting: a novel approach to cancer treatment 抗血管靶向:癌症治疗的新途径
Pharmaceutical science & technology today Pub Date : 2000-01-01 DOI: 10.1016/S1461-5347(99)00229-1
Anya Hillery
{"title":"Anti-vascular targeting: a novel approach to cancer treatment","authors":"Anya Hillery","doi":"10.1016/S1461-5347(99)00229-1","DOIUrl":"10.1016/S1461-5347(99)00229-1","url":null,"abstract":"","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":"3 1","pages":"Page 4"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00229-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human airway epithelial cell lines for in vitro drug transport and metabolism studies 人气道上皮细胞系体外药物转运和代谢研究
Pharmaceutical science & technology today Pub Date : 2000-01-01 DOI: 10.1016/S1461-5347(99)00231-X
Ben Forbes
{"title":"Human airway epithelial cell lines for in vitro drug transport and metabolism studies","authors":"Ben Forbes","doi":"10.1016/S1461-5347(99)00231-X","DOIUrl":"10.1016/S1461-5347(99)00231-X","url":null,"abstract":"<div><p>The pharmaceutical industry relies on appropriate <em>in vitro</em> models for the evaluation of drug absorption and metabolism. Despite increasing interest in drug delivery via the lung, there is currently no widely accepted cell culture model of the airway epithelium. This review considers the airway epithelium, the culture of airway epithelial cells and the need for cell lines which can model the airway epithelium. Three of the most promising human bronchial cell lines, 16HBE14o–, Calu-3 and BEAS-2B, are reviewed, with emphasis on their recent application for the study of drug transport, drug metabolism and gene delivery. Current limitations and future directions for the development of these cell lines as models of the airway epithelium are discussed.</p></div>","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":"3 1","pages":"Pages 18-27"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00231-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 155
Quantitative structure–property relationships in pharmaceutical research – Part 1 药物研究中的定量结构-性质关系。第1部分
Pharmaceutical science & technology today Pub Date : 2000-01-01 DOI: 10.1016/S1461-5347(99)00214-X
Manish Grover , Bhupinder Singh , Monika Bakshi , Saranjit Singh
{"title":"Quantitative structure–property relationships in pharmaceutical research – Part 1","authors":"Manish Grover ,&nbsp;Bhupinder Singh ,&nbsp;Monika Bakshi ,&nbsp;Saranjit Singh","doi":"10.1016/S1461-5347(99)00214-X","DOIUrl":"10.1016/S1461-5347(99)00214-X","url":null,"abstract":"<div><p>Quantitative structure–activity relationships (QSAR) have been applied for decades in the development of new drugs. Although a QSAR does not completely eliminate the trial and error factor involved in the development of a new drug, it certainly decreases the number of compounds synthesized by facilitating the selection of the most promising examples. The success of QSAR has tempted scientists, particularly in the pharmaceutical arena, to investigate relationships of molecular parameters with properties other than activity. The purpose of this two-part review is to provide a broad overview of the development of quantitative structure–property relationships (QSPR) and review the applications in pharmaceutical research. Part one discusses the advantages and limitations of QSPR, and various types of structural descriptors and properties, together with techniques to establish correlations between the two.</p></div>","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":"3 1","pages":"Pages 28-35"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00214-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 109
Monitor: progress and profiles 监控:进度和概要文件
Pharmaceutical science & technology today Pub Date : 2000-01-01 DOI: 10.1016/S1461-5347(99)00234-5
Andrew W Lloyd (Monitor Editor), A.Christy Hunter (Monitor Editor)
{"title":"Monitor: progress and profiles","authors":"Andrew W Lloyd (Monitor Editor),&nbsp;A.Christy Hunter (Monitor Editor)","doi":"10.1016/S1461-5347(99)00234-5","DOIUrl":"10.1016/S1461-5347(99)00234-5","url":null,"abstract":"<div><p><em>Monitor</em> provides an insight into the latest developments in pharmaceutical science and technology through brief synopses of recent presentations, publications and patents, and expert commentaries on the latest technologies. There are two sections: <em>Progress</em> summarizes the latest developments in pharmaceutical process technology, formulation, analytical technology, sterilization, controlled drug delivery systems and regulatory issues; <em>Profiles</em> offers expert commentary on emerging technologies, novel processes and strategic, organizational and logistic issues underlying pharmaceutical R&amp;D.</p></div>","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":"3 1","pages":"Pages 42-45"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00234-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous penetration enhancers: local versus transdermal activity 经皮渗透增强剂:局部与透皮活性
Pharmaceutical science & technology today Pub Date : 2000-01-01 DOI: 10.1016/S1461-5347(99)00225-4
Charles S Asbill, Bozena B Michniak
{"title":"Percutaneous penetration enhancers: local versus transdermal activity","authors":"Charles S Asbill,&nbsp;Bozena B Michniak","doi":"10.1016/S1461-5347(99)00225-4","DOIUrl":"10.1016/S1461-5347(99)00225-4","url":null,"abstract":"<div><p><span>The stratum corneum, poses a formidable challenge to formulators of drug delivery systems. Several approaches have been utilized to facilitate entry of drugs into the lower skin layers. Traditionally, permeation enhancers were designed to deliver high drug concentrations across the skin into the </span>systemic circulation<span>. The use of many of these agents resulted in unpleasant or toxic side effects. However, in recent years there has been a search for compounds that exhibit low toxicity, and maintain their enhancing activity. More recently, there has been interest in agents that may be used in topical formulations to prevent the passage of active ingredients or excipients into the lower skin layers. These so-called skin retardants have potential uses in many over-the-counter (OTC) skin formulations, such as sunscreens and pesticides, where the site of action is restricted to the skin surface or upper skin layers. Research in the area of permeation enhancement or retardation is yielding valuable insights into the structure–activity relationships of enhancers as well as retardants.</span></p></div>","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":"3 1","pages":"Pages 36-41"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00225-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 137
US licence for COMT inhibitor to boost levodopa effect in Parkinson’s 美国许可COMT抑制剂增强帕金森左旋多巴效应
Pharmaceutical science & technology today Pub Date : 2000-01-01 DOI: 10.1016/S1461-5347(99)00230-8
David Bradley
{"title":"US licence for COMT inhibitor to boost levodopa effect in Parkinson’s","authors":"David Bradley","doi":"10.1016/S1461-5347(99)00230-8","DOIUrl":"10.1016/S1461-5347(99)00230-8","url":null,"abstract":"","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":"3 1","pages":"Page 7"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00230-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FDA approves new immunosuppressants FDA批准新的免疫抑制剂
Pharmaceutical science & technology today Pub Date : 1999-12-01 DOI: 10.1016/S1461-5347(99)00222-9
David Bradley
{"title":"FDA approves new immunosuppressants","authors":"David Bradley","doi":"10.1016/S1461-5347(99)00222-9","DOIUrl":"10.1016/S1461-5347(99)00222-9","url":null,"abstract":"","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":"2 12","pages":"Page 472"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00222-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21460142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Aging processes in pharmaceutical polymers 药用聚合物的老化过程
Pharmaceutical science & technology today Pub Date : 1999-12-01 DOI: 10.1016/S1461-5347(99)00210-2
Jian-Hwa Guo
{"title":"Aging processes in pharmaceutical polymers","authors":"Jian-Hwa Guo","doi":"10.1016/S1461-5347(99)00210-2","DOIUrl":"10.1016/S1461-5347(99)00210-2","url":null,"abstract":"<div><p>In the practical field of solid pharmaceutical formulations, studies of the physical aging of polymers and the stability of dosage forms are of great importance. Polymers are the additives used to convert pharmacologically active compounds into pharmaceutical dosage forms suitable for administration to patients, and thus a knowledge of the physical aging effects on the stability of final products is essential. In this review, the author attempts to elucidate the fundamental concepts of physical aging in polymers, and correlate the effects of physical aging on the properties with changes in solid dosage form stability.</p></div>","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":"2 12","pages":"Pages 478-483"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00210-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21460145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Pegylated liposomal adriamycin: a review of current and future applications 聚乙二醇脂质体阿霉素:目前和未来的应用综述
Pharmaceutical science & technology today Pub Date : 1999-12-01 DOI: 10.1016/S1461-5347(99)00217-5
Conrad R Lewanski, Simon Stewart
{"title":"Pegylated liposomal adriamycin: a review of current and future applications","authors":"Conrad R Lewanski,&nbsp;Simon Stewart","doi":"10.1016/S1461-5347(99)00217-5","DOIUrl":"10.1016/S1461-5347(99)00217-5","url":null,"abstract":"<div><p><span>Anthracyclines<span> such as adriamycin have a broad spectrum of activity in human tumours, but are limited, to an extent, by their non-selective delivery to a host of normal tissues and hence, subsequent toxicity. The development of </span></span>liposomes<span> has offered a drug delivery system with significant potential to target tumours whilst sparing normal tissues. A significant breakthrough has been achieved by coating the liposome with polyethylene glycol<span> (pegylation), and thus altering the pharmacokinetics of the drug considerably. In this review, the authors discuss the promising data now emerging with pegylated liposomal adriamycin, and also describe possible future applications.</span></span></p></div>","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":"2 12","pages":"Pages 473-477"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00217-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21460144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Synthesis and applications of novel, highly efficient HPLC chiral stationary phases: a chiral dimension in drug research analysis 新型高效高效液相色谱手性固定相的合成与应用:药物研究分析中的手性维度
Pharmaceutical science & technology today Pub Date : 1999-12-01 DOI: 10.1016/S1461-5347(99)00218-7
Giovanna Cancelliere , Ilaria D’Acquarica , Francesco Gasparrini , Domenico Misiti , Claudio Villani
{"title":"Synthesis and applications of novel, highly efficient HPLC chiral stationary phases: a chiral dimension in drug research analysis","authors":"Giovanna Cancelliere ,&nbsp;Ilaria D’Acquarica ,&nbsp;Francesco Gasparrini ,&nbsp;Domenico Misiti ,&nbsp;Claudio Villani","doi":"10.1016/S1461-5347(99)00218-7","DOIUrl":"10.1016/S1461-5347(99)00218-7","url":null,"abstract":"<div><p>This review provides an overview of the synthesis and application of stable and versatile HPLC chiral stationary phases (CSPs), with emphasis placed on the binding strategies developed to anchor several structurally different chiral selectors to silica-gel microparticles. In addition, selected applications relating to the use of these CSPs for the direct resolution of racemates of biological and pharmaceutical relevance will be described. This review discusses enantioselective molecular recognition and dynamic stereochemistry of stereolabile compounds with reference to receptor-based chiral stationary phases (CSPs) and dynamic HPLC on CSPs, respectively.</p></div>","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":"2 12","pages":"Pages 484-492"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00218-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21460146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信